ReviewSpringer seminars in immunopathology1993
FK 506: a novel immunosuppressant for treatment of autoimmune disease. Rationale and preliminary clinical experience at the University of Pittsburgh.
Review in Springer seminars in immunopathology, 1993. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed.
- Trial
- Article
- Diabetes tolerogenic vaccines targeting antigen-specific inflammation.Human vaccines & immunotherapeutics · 2015Review
- Steroid-sparing effect of tacrolimus in a patient with juvenile dermatomyositis presenting poor bioavailability of cyclosporine A.European journal of pediatrics · 2004Article
- Tacrolimus in refractory polymyositis with interstitial lung disease.Lancet (London, England) · 1999Article
- The use of therapeutic drug monitoring to optimise immunosuppressive therapy.Clinical pharmacokinetics · 1996Review
- Autoimmune hepatitis. Evolving concepts and treatment strategies.Digestive diseases and sciences · 1995Review
- Therapeutic advances in immunosuppression.Clinical and experimental immunology · 1994Review
- Circulating intercellular adhesion molecule-1 (ICAM-1) in autoimmune liver disease and evidence for the production of ICAM-1 by cytokine-stimulated human hepatocytes.Clinical and experimental immunology · 1994Article
- New immunosuppressive drugs: mechanistic insights and potential therapeutic advances.Immunological reviews · 1993Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.